Chart: Taxing Based On Risk Class?
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed's push for a graduated tax rate based on FDA risk classification category is intended as a way to "recognize the diversity of industry," according to CEO Steve Ubl. Essentially, it would provide a break to firms with higher-volume, lower-profit-margin products, such as hospital supply commodities.